Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04289571 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 626 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor 8 versions Re-verified since Mar 4, 2025, no change to tracked fieldsv619-v626
  2. Minor Eligibility criteria expanded, about 50 wordsv618
  3. Notable Primary endpoint revised
    • Interventions: VR Motility Tool (Diagnostic Test) to VR Mobility Tool (Diagnostic Test)
    • Secondary endpoints: 3 to 6
    v617
  4. Minor 7 versions Re-verified since Aug 11, 2023, no change to tracked fieldsv610-v616
  5. Minor Start date: Jul 26, 2023 to Jul 25, 2023v609
Show 32 earlier versionsHide 32 earlier versions
  1. Minor Start date changed from estimate of Aug 2, 2023 to Jul 26, 2023v608
  2. Minor Start date: Jul 31, 2023 to Aug 2, 2023v607
  3. Minor Start date: Jul 30, 2023 to Jul 31, 2023v606
  4. Minor Start date: Jul 27, 2023 to Jul 30, 2023v605
  5. Minor Start date: Jul 26, 2023 to Jul 27, 2023v604
  6. Minor Start date: Jul 25, 2023 to Jul 26, 2023v603
  7. Minor Start date: Jul 24, 2023 to Jul 25, 2023v602
  8. Minor Start date: Jul 23, 2023 to Jul 24, 2023v601
  9. Minor Start date: Jul 20, 2023 to Jul 23, 2023v600
  10. Minor Start date: Jul 18, 2023 to Jul 20, 2023v599
  11. Minor Start date: Jul 17, 2023 to Jul 18, 2023v598
  12. Minor Start date: Jul 16, 2023 to Jul 17, 2023v597
  13. Minor Start date: Jul 13, 2023 to Jul 16, 2023v596
  14. Minor Start date: Jul 12, 2023 to Jul 13, 2023v595
  15. Minor Start date: Jul 11, 2023 to Jul 12, 2023v594
  16. Minor Start date: Jul 9, 2023 to Jul 11, 2023v593
  17. Minor Start date: Jul 6, 2023 to Jul 9, 2023v592
  18. Minor Start date: Jul 5, 2023 to Jul 6, 2023v591
  19. Minor Start date: Jul 4, 2023 to Jul 5, 2023v590
  20. Minor Start date: Jul 3, 2023 to Jul 4, 2023v589
  21. Minor Start date: Jul 2, 2023 to Jul 3, 2023v588
  22. Minor Start date: Jun 29, 2023 to Jul 2, 2023v587
  23. Minor Start date: Jun 28, 2023 to Jun 29, 2023v586
  24. Minor Start date: Jun 27, 2023 to Jun 28, 2023v585
  25. Minor Start date: Jun 22, 2023 to Jun 27, 2023v584
  26. Minor Start date: Jun 21, 2023 to Jun 22, 2023v583
  27. Minor Start date: Jun 20, 2023 to Jun 21, 2023v582
  28. Minor Start date: Jun 19, 2023 to Jun 20, 2023v581
  29. Minor Start date: Jun 18, 2023 to Jun 19, 2023v580
  30. Minor Start date: Jun 15, 2023 to Jun 18, 2023v579
  31. Minor Start date: Jun 14, 2023 to Jun 15, 2023v578
  32. Minor Start date: Jun 13, 2023 to Jun 14, 2023v577
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: The retina is a thin layer of tissue at the back of the eye. Retinal disease usually reduces a person s mobility because it affects how he or she moves through familiar and unfamiliar environments. Researchers want to see if a virtual reality (VR) tool can provide an easier and more accurate way to assess mobility. Objective: To learn if researchers can track changes in mobility in people with retinal disease using a new VR tool. Eligibility: People aged 5 and older with retinal disease that affects their vision, and healthy volunteers. Design: Participants will have 2-3 clinic visits. Participants will wear goggles or sit in front of a screen while sitting. Using a game controller, they will navigate through 4 obstacle courses presented in VR. Participants will have a medical history exam. They will answer questions about their family history. They will fill out questionnaires about the vision and mobility issues they have in their daily lives. Participants will have a complete eye exam. They will read letters from a chart. Their eye pressure will be measured. Their pupils may be dilated with eye drops. Pictures of their eye will be taken. Lights will be shined in their eyes. Participants will take a visual field test. For this, they will look into a dome and press a button when they see a light. Participants will have an electroretinogram. For this, they will sit in the dark with their eyes patched. Then their eyes will be numbed with eye drops and they will wear contact lenses while watching flashing lights. Participants will have optical coherence tomography. This is a noninvasive procedure. It produces cross-sectional pictures of the retina....
Trial Details
NCT Number NCT04289571
Lead Sponsor National Eye Institute (NEI)
Conditions
(from sponsor)
Cone-Rod Degeneration, Rod-Cone Degeneration
Related terms Cone-Rod Dystrophies
Enrollment 165 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov